We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Immuno-Oncology/Oncology
Modeling Chimeric Antigen Receptor (CARS) and T Cell Bispecific (TCB) Therapies in Mice

Modeling Chimeric Antigen Receptor (CARS) and T Cell Bispecific (TCB) Therapies in Mice

Published Date June 30, 2021

Modeling chimeric antigen receptor (CARS) and T cell bispecific (TCB) therapies in mice

Loading, please wait

Error - something went wrong!

Don't miss new content. Subscribe to our monthly newsletter, JAX Pulse!

Thank you!

Previous Article

Genetically Diverse Mouse Models for Every Stage of the Research Pipeline

Mouse research is often performed in genetically-defined inbred mouse strains, where each mouse within a strain is virtually identical to one another.
Next Video

JAX Antibody Development Summit - Jan Eckmann

Dr. Jan Eckmann, Group Leader Oncology Discovery Pharmacology at Roche, presents The Use of Humanized Mice in Antibody Drug Discovery as part of The Jackson Laboratory's Antibody Drug Development Summ

Other content in this Stream

about 1 month ago
NSG-FLT3-IL15: A More Comprehensive Immune Humanized Model for Natural Killer Cells

In this presentation, we introduce The Jackson Laboratory’s most comprehensive immune humanized mouse platform to date: NSG- FLT3-IL15.

Watch Video
8 months ago
Cancer immunotherapy: getting a little help from ourselves

We review strategies and mouse models used to develop highly promising therapeutic treatments using the body’s own immune system in the fight against cancer.

Learn More
10 months ago
Comparing Immunodeficient Models for Cancer, Immunity, and Transplant Research

January 16, 2024 - In this webinar, we discuss the most widely used immunodeficient mouse models and essential considerations for selecting the most appropriate model.

Watch Video
about 1 year ago
New Immune-humanized Models Support More Diverse Human Immune Cell Lineages

In this webinar, we will introduce two new enhanced NSG models developed at The Jackson Laboratory: NSG-SGM3-IL15 and NSG-FLT3.

Watch Video
The Promise of Cancer Genomics

Learn about the advantages of using genomic-based strategies in the fight against cancer

Learn More
Exploring Cancer Research: Tools and Technologies

Find out which tools and technologies are used by scientists to advance the field of cancer research, including sequencing, cell-based models of cancer, and mouse models of cancer.

Learn More
almost 2 years ago
Leveraging Gene Therapy to Achieve Long-Term Continuous or Controllable Expression of Biotherapeutics

Leading this presentation is guest speaker Dr. Timothy Cripe from Nationwide Children’s Hospital and The Ohio State University.

Watch Video
about 2 years ago
JAX Clinical Knowledgebase - Identify Resistance Variants in Preclinical Drug Testing

One of the major challenges oncologists are often faced with when managing precision cancer treatment is acquired drug resistance.

Learn More
about 2 years ago
Making a Case for Preclinical Data - The JAX Clinical Knowledgebase

The JAX Clinical Knowledgebase (CKB) is a relational database that contains data associated with cancer variants, tumor types, and therapies.

Learn More
about 2 years ago
A Novel In Vivo Model to Simultaneously Assess Efficacy and Toxicity of Chimeric Antigen Receptor T-Cell Immunotherapy

Read Flipbook
Exploring Cancer: Biology and Inheritance

Discover the fundamental properties of cancer cells and explore the genetic basis, inheritance, risk factors and prevention of this disease.

Learn More
over 2 years ago
Immune-Humanized PDX Model-Estrogen-Independent, Hormone Receptor-Positive Metastatic Breast Cancer

The most common type of breast cancer is estrogen receptor-positive (ER+). ER+ tumors can be successfully treated with hormone therapy, but many tumors acquire endocrine resistance which limits treatm

Watch Video
over 2 years ago
Predictive Pre Clinical Oncology Studies Using Patient-Derived Xenograft Platforms

This on-demand webinar provides strategies for using PDX models in predictive preclinical research and an introduction to PDX models for immuno-oncology research.

Watch Video
over 2 years ago
How To Make Your New NSG Variant in a Fraction of the Time

CRISPR/Cas9 can quickly generate new translational mouse models directly on the genetic background needed for your preclinical research. This saves valuable research time by reducing the need for...

Learn More
over 2 years ago
Achieving Relevant Preclinical Characterization of CAR T Cell Therapies

This whitepaper examines the constraints and challenges inherent in each CAR T study type and how to overcome them with in vivo studies using fully humanized mouse models.

Read Flipbook
over 2 years ago
Designing Your In Vivo Studies

September 9, 2021 - Learn about unique experimental design considerations and critically important topics that affect the reproducibility of your In Vivo research studies.

Watch Video
almost 3 years ago
JAX Tech Talk Episode 48: Developing Immunotherapies with Hu-NSG-MHC I/II DKO Mice (Jan. 11, 2022)

January 11, 2022 - In this episode, we will discuss using PBMC humanized NSG-MHC I/II DKO mice in preclinical research to develop and assess efficacy of human immuno-therapeutics.

Watch Video
almost 3 years ago
JAX Tech Talk Episode 47: Let’s Talk Navigating the JAX Clinical Knowledgebase (Dec. 14, 2021)

oin us as we talk with a JAX-CKB curator about what goes into the knowledgebase.

Watch Video
almost 3 years ago
Introduction to In Vivo Platforms for Cancer Immunotherapy

Grace Berryhill, Ph.D. provides an overview of in vivo platforms being used to improve the translational relevance of cancer immunotherapies.

Watch Video
about 3 years ago
Human KIT+ Myeloid Cells Facilitate Visceral Metastasis By Melanoma

Chun Yu, Ph.D., Associate Research Scientist at The Jackson Laboratory speaks about Human KIT+ myeloid cells and how they facilitate visceral metastasis by melanoma.

Watch Video

Recommended for you

Return to Home

© The Jackson Laboratory